# Clinical and Basic Research of ETV Plus GM-CSF in Chronic Hepatitis B Patients

> **NCT03164889** · NA · TERMINATED · sponsor: **Beijing 302 Hospital** · enrollment: 80 (actual)

## Conditions studied

- Hepatitis B, Chronic

## Interventions

- **DRUG:** Granulocyte Macrophage-colony Stimulating Factor
- **DRUG:** Entecavir

## Key facts

- **NCT ID:** NCT03164889
- **Lead sponsor:** Beijing 302 Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-01
- **Primary completion:** 2018-01-01
- **Final completion:** 2021-12-01
- **Target enrollment:** 80 (ACTUAL)
- **Why stopped:** no enough participant can be enrolled
- **Last updated:** 2022-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03164889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03164889, "Clinical and Basic Research of ETV Plus GM-CSF in Chronic Hepatitis B Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03164889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*